Skip to main content
Premium Trial:

Request an Annual Quote

BC Cancer Agency Joins Illumina Network; Ambry Offering MiSeq Services

NEW YORK (GenomeWeb News) – The British Columbia Cancer Agency Genome Science Center has joined the Illumina Genome Network, the San Diego-based firm said this week.

Research institutes that join the IGN have completed the firm's Certified Service Provider certification. Each of the partners in the network also have at least 10 Illumina sequencing systems.

The BC Cancer Agency is part of the Canadian Provincial Health Services Authority and provides a range of oncology services to patients in the province. Its Genome Science Center provides genomic services to researchers around the world.

In a separate announcement, Ambry Genetics said that it has begun offering services on Illumina's MiSeq next-generation sequencing platform. The Aliso, Viejo, Calif.-based CLIA-certified lab and analytical services provider, has offered services on Illumina's other sequencing platforms since 2007 and is a Certified Service Provider for the firm.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more